AI assistant
Sending…
Oxford Biomedica PLC — Major Shareholding Notification 2015
Jun 15, 2015
5190_dirs_2015-06-15_1648fca6-c3b1-46c0-a350-9623f3972ae0.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1582Q
Oxford Biomedica PLC
15 June 2015
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
| 1 | Issuer | Oxford BioMedica PLC |
| 2 | Reason for notification | Notification relates to DTR 3.1.2R |
| 3 | Name of PDMR | Martin Diggle |
| 4 | Connected person | Notification relates to following connected persons: Vulpes Life Sciences Fund |
| 5 | Notification in respect of | Notification in respect of holdings of persons in 4 above |
| 6 | Description of shares | Oxford BioMedica PLC ordinary shares of 1p each |
| 7 | Name of registered shareholders and number of shares | Vulpes Life Sciences Fund - 449,716,022 shares |
| 8 | Nature of transaction | Acquisition |
| 9 | Number of shares acquired | Vulpes Life Sciences Fund - 283,978 shares |
| 10 | Percentage of issued class acquired | Vulpes Life Sciences Fund - 0.01% |
| 11 | Shares disposed | N/A |
| 12 | Percentage of issued class disposed | N/A |
| 13/14 | Price per share of transactions, and date | Vulpes Life Sciences Fund 283,978 shares @ £0.0901 , 12 June 2015 |
| 15 | Total holding following notification and total percentage holding following notification | Vulpes Life Sciences Fund - 450,000,000 shares 17.52% |
| 16 | Date issuer informed | 15 June 2015 |
| 23 | Any additional information | None |
| 24 | Contact name and telephone number | T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000 |
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBGGDLDDBBGUU
More from Oxford Biomedica PLC
Director's Dealing
2026
May 22
Director's Dealing
2026
May 19
Director's Dealing
2026
May 13
AGM Information
2026
May 11
Regulatory Filings
2026
May 7
AGM Information
2026
May 7
Declaration of Voting Results & Voting Rights Announcements
2026
May 1
Regulatory Filings
2026
Apr 30
Share Issue/Capital Change
2026
Apr 27
Regulatory Filings
2026
Apr 13